Knight Therapeutics Closes $50MM Revolving Credit Facility with National Bank of Canada
Knight Therapeutics, a pan-American (ex-U.S.) specialty pharmaceutical company, entered into a revolving credit facility with National Bank of Canada (NBC). Knight has withdrawn C$60 million from the credit facility to fund a portion of the Paladin acquisition. The credit facility...
Read moreDetails









